WHO report highlights global burden of alcohol and drug-related deaths

FHS
June 25, 2024
7:03 pm

A new report from the World Health Organization (WHO) highlights that 2.6 million deaths per year were attributable to alcohol consumption, accounting for 4.7% of all deaths, and 0.6 million deaths to psychoactive drug use.

What Novo Nordisk’s disappointing trial results mean for the obesity drug market

The long-standing edge that Novo Nordisk has held in the obesity drug market was thrown into question Friday when the company reported results of a

December 20, 2024

The Future of Psychedelic Access in Canada: PsyCan Releases White Paper Reviewing Regulatory Options for Psychedelics | Psychedelic Invest

PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — is pleased to share its 2023 White Paper on the future of psychedelic access

October 3, 2023

Wegovy cut patients’ chances of dying from Covid-19, new analysis shows

LONDON — Novo Nordisk made worldwide headlines last year when a study demonstrated that Wegovy, its powerful and exceedingly popular weight loss medicine, helped reduce

August 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.